www.Mammographiescreening.org

Hinweise zum Projekt der Kassenärzlichen Bundesvereinigung Deutschland
 von Michael Venator, Bergisch Gladbach

Startseite Fakten

Empfehlungen

Impressum
 

zurück
 

Diese Tabelle zur Qualitätskontrolle im Screening ist im BIRADS, amerikanische Originalausgabe, sowohl in der 3. wie in der 4. Auflage empfohlen:
Quelle:
Bassett LW, Hendrick RE, Bassford TL, et al. Quality Determinants of Mammography. Clinical Practice Guideline No. 13. AHCPR Publication No. 95-0632. Rockville, Md: Agency for Health Care Policy and Research, Public Health Service, U.S. Department of Health and Human Services, October 1994: 83
PPV1 based on abnormal screening examination 5-10%
PPV2 when biopsy (surgical, FNA, or core) recommended 25-40%
Tumors found-Stage 0 or 1 >50%
Tumors found-Minimal cancer 1 >30%
Node positivity <25%
Cancers found per 1,000 cases 2-10
Prevalent cancers found per 1,000 first-time examinations 6-10
Incident cancers found per 1,000 follow-up examinations 2-4
Recall rate <10%
Sensitivity (if measurable) >85%
Specificity (if measurable) >90%